NCT05618925 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05618925
Title	Study for Subjects With Relapsed/Refractory Non- Hodgkin Lymphoma
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	ImmunityBio, Inc.
Indications	non-Hodgkin lymphoma
Therapies	Cyclophosphamide + Fludarabine CD19 t-haNK cells + Rituximab CD19 t-haNK cells + Nogapendekin alfa inbakicept + Rituximab
Age Groups:	senior \| adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Hoag Memorial Hospital	RECRUITING	Newport Beach	California	92663	United States	Details
Texas Oncology	RECRUITING	Tyler	Texas	75702	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT05618925Clinical Trial Detail